Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02404818 · ClinicalTrials.gov registry record

Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation Therapy

A clinical trial, sponsored by University of Florida.

Completed
Registry status
5
Enrollment target

NCT02404818: Completed study, sponsored by University of Florida.

NCT02404818 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02404818 has completed, sponsored by University of Florida.

COMPLETED
Registry status
5 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate if radiation and chemotherapy treatment cause cardiac abnormalities among survivors of Hodgkin's lymphoma.

Interventions

  • PROCEDURE Echocardiogram
  • PROCEDURE Cardiac Magnetic Resonance Imaging

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2015-04
Est. Completion 2021-04-14
University of Florida

1,106 total trials

What the finished NCT02404818 record still lists

NCT02404818 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which Echocardiogram is the first listed.

NCT02404818 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02404818 about?

NCT02404818 is a clinical study titled "Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation Therapy". The purpose of this study is to evaluate if radiation and chemotherapy treatment cause cardiac abnormalities among survivors of Hodgkin's lymphoma.

What is the current status of trial NCT02404818?

This trial is currently completed. The enrollment target is 5 participants. The study started on 2015-04. Estimated completion is 2021-04-14.

What interventions are being tested in trial NCT02404818?

The interventions under investigation include: Echocardiogram (PROCEDURE), Cardiac Magnetic Resonance Imaging (PROCEDURE).

Who is sponsoring clinical trial NCT02404818?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02404818, the US trial registry maintained by the National Library of Medicine. NCT02404818 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.